TD Waterhouse Canada Inc. Buys 22,588 Shares of SPDR S&P Biotech ETF $XBI

TD Waterhouse Canada Inc. lifted its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 429.0% in the third quarter, HoldingsChannel reports. The institutional investor owned 27,853 shares of the exchange traded fund’s stock after buying an additional 22,588 shares during the quarter. TD Waterhouse Canada Inc.’s holdings in SPDR S&P Biotech ETF were worth $4,311,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also modified their holdings of the company. Bank of America Corp DE boosted its holdings in shares of SPDR S&P Biotech ETF by 13.3% in the 1st quarter. Bank of America Corp DE now owns 14,518,027 shares of the exchange traded fund’s stock worth $1,854,388,000 after acquiring an additional 1,700,851 shares in the last quarter. Main Street Research LLC lifted its position in shares of SPDR S&P Biotech ETF by 57.4% during the first quarter. Main Street Research LLC now owns 567,479 shares of the exchange traded fund’s stock worth $72,484,000 after purchasing an additional 206,953 shares in the last quarter. Northwestern Mutual Wealth Management Co. lifted its position in shares of SPDR S&P Biotech ETF by 145.7% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 314,224 shares of the exchange traded fund’s stock worth $49,726,000 after purchasing an additional 186,314 shares in the last quarter. Wellington Management Group LLP bought a new stake in shares of SPDR S&P Biotech ETF during the second quarter valued at approximately $19,270,000. Finally, SG Americas Securities LLC grew its stake in shares of SPDR S&P Biotech ETF by 41.4% during the first quarter. SG Americas Securities LLC now owns 391,243 shares of the exchange traded fund’s stock valued at $49,973,000 after purchasing an additional 114,638 shares during the last quarter.

SPDR S&P Biotech ETF Price Performance

Shares of SPDR S&P Biotech ETF stock opened at $147.86 on Tuesday. The firm has a market cap of $10.21 billion, a P/E ratio of 11.47 and a beta of 0.83. The firm has a 50 day simple moving average of $157.89 and a 200 day simple moving average of $147.21. SPDR S&P Biotech ETF has a fifty-two week low of $106.30 and a fifty-two week high of $169.89.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.